secwatch.observer — SEC 8-K summary
======================================

Issuer:     Eloxx Pharmaceuticals, Inc. (ELOX)
CIK:        0001035354
Form:       8-K
Filed at:   2025-08-12T23:59:59+00:00
Accession:  0001104659-25-076933
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Director Lindsay Androski resigns from Eloxx board effective August 6, 2025
---------------------------------------------------------------------------

- Lindsay Androski notified the Board of her resignation, effective immediately on August 6, 2025.
- Resignation was not due to any disagreement with the Company's operations, policies, or practices.
- No replacement director has been announced; board size reduced accordingly.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1035354/000110465925076933/0001104659-25-076933-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1035354/000110465925076933/tm2523236d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-076933

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer